Investor's Business Daily on MSN
Kiniksa Pharmaceuticals sees its composite rating rise to 96
Kiniksa Pharmaceuticals KNSA saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 94 the day before. Please ...
BOSTON--(BUSINESS WIRE)--Harnessing the power of machine learning and billions of commercial and government claims covering more than 215 million lives and over 2.6 million providers, ConsumerMedical ...
US— Toluna has introduced a new methodology to select online survey respondents based on the demographic, attitudinal and behavioural characteristics of target populations. Chief research officer John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback